Introducing Geoff Parnell: New Board Chair of GI Cancer Trials
As GI Cancer Trials enters its next chapter, we are pleased to welcome Geoff Parnell as our new... Read More
As GI Cancer Trials enters its next chapter, we are pleased to welcome Geoff Parnell as our new... Read More
We are pleased to welcome new leadership to our Community Advisory Panel (CAP), with Jodie Collins stepping into... Read More
As we farewell Jeff from his role as Chair of our Community Advisory Panel (CAP), we reflect on... Read More
As GI Cancer Trials enters a new chapter, we acknowledge and thank our outgoing Chair, Lorraine Chantrill, for... Read More
Trial news: We currently have 4 studies open to recruitment and 19 studies in follow up. The... Read More
The annual Excellence in Site Performance Awards recognise clinical trial sites that have shown exceptional enthusiasm, performance and... Read More
A key focus for GI Cancer Trials is fostering the development of early career researchers. In 2022 we... Read More
Professor Tim Price received the John Zalcberg AO Award for Excellence in GI Cancer Research... Read More
We’re thrilled to share that the PemOla study, which is investigating a potential combined immunotherapy treatment for metastatic... Read More
We are proud to announce Dr Thomas Hansen as the recipient of the Russell Conley Anal Cancer Grant. This... Read More
We are unifying our identity under a single name – GI Cancer Trials – to better reflect our... Read More
MEDIA RELEASE – Download PDF AGITG DYNAMIC-III clinical trial findings published in Nature Medicine and presented at the... Read More
Professor David Goldstein has presented results from the Australasian Gastro-Intestinal Trials Group’s INTEGRATE IIb study at the 2025... Read More
The 2025 Preceptorship in Colorectal Cancer brought together 29 early-career healthcare professionals and 11 experts across medical oncology,... Read More
The community-funded clinical trial OXTOX, a colorectal cancer study, has completed patient enrolment. Excitingly, this trial reached their... Read More
A new Australian multi-centre trial investigating the impact of MRI-guided radiotherapy on oligometastatic abdominal cancers is now open. The... Read More
Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’s Certepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer MEDIA RELEASE – Download PDF Key points: ASCEND comprises two dosing regimens of certepetide... Read More
The theme for the ASCO 2025 Meeting was Driving Knowledge to Action: Building a Better Future, focusing on... Read More
A new signal-seeking study, investigating a novel treatment vaccine for patients with colorectal cancer, is now open in... Read More
This year’s Idea Generation Workshop, held on 15 May, welcomed a record number of participants and a diverse range of ideas focusing on young-onset GI cancer research. The workshop theme was timely given the growing global concern about the increasing incidence of GI cancer in young adults. Australia has one of... Read More